Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 12/2016

01-12-2016 | Erratum

Erratum to: Severe Acute Hepatocellular Injury Attributed to OxyELITE Pro: A Case Series

Authors: Lauren A. Heidemann, Victor J. Navarro, Jawad Ahmad, Paul H. Hayashi, Andrew Stolz, David E. Kleiner, Robert J. Fontana

Published in: Digestive Diseases and Sciences | Issue 12/2016

Login to get access

Excerpt

The authors of the article have requested the publication of this erratum since the authors now state that a product described in the case series, OxyELITE Pro, does not contain green tea extract, in contrast to what was stated in the article. Accordingly, the following text and literature citations should be considered as deleted from the publication: …
Literature
20.
Navarro VJ, Bonkovsky HL, Hwang SI, Vega M, Barnhart H, Serrano J. Catechins in dietary supplements and hepatotoxicity. Dig Dis Sci. 2013;58:2682–2690.CrossRefPubMedPubMedCentral
21.
Bonkovsky HL. Hepatotoxicity associated with supplements containing Chinese Green tea (Camellia sinesis). Ann Intern Med. 2006;144:68–71.CrossRefPubMed
22.
Kapetanovic IM, Crowell JA, Krishnaraj R, Zakharov A, Lindeblad M, Lyubimov A. Exposure and toxicity of green tea polyphenols in fasted and non-fasted dogs. Toxicology. 2009;260:28–36.CrossRefPubMedPubMedCentral
23.
Lambert JD, Kennett MJ, Sang S, Reuhl KR, Ju J, Yang CS. Hepatotoxicity of high oral dose (−) epigallocatechin-3-gallate in mice. Food Chem Toxicol. 2010;48:409–416.CrossRefPubMed
Metadata
Title
Erratum to: Severe Acute Hepatocellular Injury Attributed to OxyELITE Pro: A Case Series
Authors
Lauren A. Heidemann
Victor J. Navarro
Jawad Ahmad
Paul H. Hayashi
Andrew Stolz
David E. Kleiner
Robert J. Fontana
Publication date
01-12-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 12/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4290-3

Other articles of this Issue 12/2016

Digestive Diseases and Sciences 12/2016 Go to the issue

Fellows and Young Gis Section

Incorporating Clinical Research into a Career in Gastroenterology and Hepatology

DDS Mentored Reviews

FXR Agonists: From Bench to Bedside, a Guide for Clinicians

Original Article

Endoscopic Submucosal Dissection of Superficial Esophageal Neoplasms Is Feasible and Not Riskier for Patients with Liver Cirrhosis

Original Article

Endoscopic Management of Large (≥2 cm) Non-pedunculated Colorectal Polyps: Impact of Polyp Morphology on Outcomes

PROFILES AND PERSPECTIVES

Profiles: Raymond S. Koff, MD

Original Article

Esophagogastric Junction Morphology and Distal Esophageal Acid Exposure
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits